However, upregulated interferon‐stimulated gene (ISG) transcripts in blood have proven to be the most robust diagnostic biomarker in AGS patients, and an “ISG signature” often persists long after the initial stages of disease (Rice et al, 2013; Crow et al, 2015). This evidence concerns the gene STING1 and Aicardi-Goutieres syndrome.